NEU neuren pharmaceuticals limited

Ann: Q4 2021 quarterly activity and cash flow report, page-25

  1. 183 Posts.
    lightbulb Created with Sketch. 99
    I have re-listened to Jon's presentation and there is one thing that have caught my attention and I consider it very important when it comes to milestone payments. He stated: (time stamp 29.55)
    .....this $111 million over 2022 and 2023 is split between "TWO REGULATORY" milestone payments....

    IMO, the next 2 regulatory milestones are:
    - NDA lodgement - mid 2022
    - NDA approval - EOY 2022/early 2023

    Other milestone which may follow could be the launch of trofinetide in 2023 after approval which may trigger a milestone payment but this is not a regulatory milestone.

    My logic tells me that a milestone payment may be triggered in mid 2022 when NDA is lodged (probably several million AUD not more than that)
    Can you please find some flaws in my logic or tell me/us what other regulatory milestone you may see which would mean that no milestone payment triggered mid 2022 when NDA is lodged?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.